Related Experiment Video
Updated: Jul 7, 2026
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Stem cell therapy in acute myocardial infarction
1Department of Cardiology, Gasthuisberg University Hospital, KU Leuven, Belgium. stefan.janssens@med.kuleuven.be
Insights
Bone marrow progenitor cell therapy shows promise for heart attack patients, improving heart function. However, challenges in cell delivery and survival hinder optimal outcomes, requiring further research into molecular mechanisms for better clinical strategies.
Area of Science:
- Cardiovascular Medicine
- Regenerative Medicine
- Cell Biology
Background:
- Myocardial infarction (MI) patients with reduced left ventricular (LV) function have poor outcomes despite current therapies.
- Progenitor cell therapy offers a potential regenerative approach for cardiac repair after MI.
- Existing bone marrow cell transfer trials show variable improvements in LV function post-MI.
Purpose of the Study:
- To investigate the mechanisms of progenitor cell-mediated cardiac repair in myocardial infarction.
- To understand the factors limiting the efficacy of cell-based cardiac repair strategies.
- To identify molecular targets for enhancing cell homing, survival, and functional recovery post-MI.
Main Methods:
- Review of preclinical models and clinical trials of bone marrow cell transfer in MI patients.
- Analysis of observed effects on LV function, myocardial perfusion, and infarct size.
- Evaluation of evidence regarding the role of cardiomyocyte formation versus other mechanisms.
Main Results:
- Bone marrow progenitor cell transfer can augment recovery of global LV function in MI patients.
- Beneficial effects include improved myocardial perfusion and enhanced regional contraction.
- These effects appear to be independent of cardiomyocyte formation.
- Limited cell homing and survival in the ischemic environment restrict therapeutic potential.
Conclusions:
- Cell-based cardiac repair holds promise for improving outcomes in myocardial infarction.
- Enhancing progenitor cell homing and survival is critical for maximizing therapeutic benefits.
- Further research into molecular mechanisms is essential for developing improved clinical strategies for cardiac repair.
Abstract:
Despite state-of-the-art therapy, clinical outcome remains poor in myocardial infarction (MI) patients with reduced left ventricular (LV) function with yearly mortality rates of approximately 15% and rehospitalization rates for heart failure or recurrent infarction within the first year exceeding 20%. Progenitor cell-mediated repair of the damaged heart is a promising new development in cardiovascular medicine. Progenitor cells residing in bone marrow and presumably also in the heart are capable of improving LV function in preclinical MI models but underlying mechanisms remain incompletely understood. Recent placebo-controlled, randomized bone marrow cell transfer trials in MI patients have shown augmented recovery of global LV function of variable magnitude. The observed changes were associated with a favourable effect on myocardial perfusion, with greater infarct size reduction, or with enhanced regional contraction in the infarct border zones. There is now growing consensus that these beneficial effects of bone marrow-derived progenitor cell transfer, as applied in post-MI patients thus far, occur independent of cardiomyocyte formation. At the same time, we have recognized that insufficient homing and survival of transplanted cells into the ischaemic milieu limits the full potential of cell-based cardiac repair. A better understanding of underlying molecular mechanisms of these critical steps in cell-based repair will, however, facilitate the development of improved clinical strategies to enhance functional recovery after myocardial infarction in the years to come.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:30Acute Coronary Syndrome I: Introduction